Mirae Asset Global ETFs Holdings’s Xenon Pharmaceuticals XENE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72M	Buy	45,014 +4,501	+11%	+$250K	﹤0.01%	1100
2026 Q1	$2.36M	Buy	40,513 +5,203	+15%	+$240K	﹤0.01%	1105
2025 Q4	$1.58M	Buy	35,310 +9	+0%	+$378	﹤0.01%	1266
2025 Q3	$1.42M	Sell	35,301 -6,347	-15%	-$224K	﹤0.01%	1301
2025 Q2	$1.3M	Buy	+41,648	New	+$1.36M	﹤0.01%	1309

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's XENE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Xenon Pharmaceuticals (XENE) stake by 11% in Q2 2026, buying an estimated $250K and bringing the position to 45,014 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Mirae Asset Global ETFs Holdings first reported a position in XENE in Q2 2025 and has held it in 5 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Mirae Asset Global ETFs Holdings held 45,014 shares of Xenon Pharmaceuticals worth $2.72M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 4,501 Xenon Pharmaceuticals shares in Q2 2026, an estimated $250K.
Xenon Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1100 holding.
Mirae Asset Global ETFs Holdings first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.